Inventor
KAS KOEN
BE14 patents
⚠️ This page may combine multiple inventors who share the name “KAS KOEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
KAS KOEN
4 patentsUS8697370B2Apr 15, 2014
Biomarker for diagnosis, prediction and/or prognosis of sepsis and uses thereof
KAS KOEN27 citations89
US8501418B2Aug 6, 2013
Method of treating renal dysfunction based on perlecan as a biomarker
KAS KOEN8 citations80
US8628979B2Jan 14, 2014
MCAM as a biomarker for fluid homeostasis
KAS KOEN4 citations71
US9465039B2Oct 11, 2016
Perlecan as a biomarker for renal dysfunction
KAS KOEN1 citations48
CARIS SCIENCE INC
4 patentsUS10995360B2May 4, 2021
Use of aptamers in proteomics
CARIS SCIENCE INC3 citations71
US10316349B2Jun 11, 2019
Use of aptamers in proteomics
CARIS SCIENCE INC3 citations71
US12116618B2Oct 15, 2024
Use of aptamers in proteomics
CARIS SCIENCE INC0 citations60
US11624083B2Apr 11, 2023
Use of aptamers in proteomics
CARIS SCIENCE INC0 citations60
MYCARTIS NV
4 patentsUS10114021B2Oct 30, 2018
Biomarker for diagnosis, prediction and/or prognosis of acute heart failure and uses thereof
MYCARTIS NV0 citations50
US9915666B2Mar 13, 2018
MCAM as a biomarker for fluid homeostasis
MYCARTIS NV0 citations50
US9791457B2Oct 17, 2017
Biomarkers for hypertensive disorders of pregnancy
MYCARTIS NV1 citations50
US9638701B2May 2, 2017
Method to determine treatment of acute heart failure
MYCARTIS NV0 citations48